General anesthetics
Highly varied class that includes ether, chloroform, nitrous oxide (laughing gas), desflurane (Suprane®), enflurane (Ethrane®), halothane (Fluothane®), isoflurane (Forane®), propofol (Diprivan®) and sevoflurane (Sevorane®).
Classification | Central nervous system depressant:
|
---|---|
Visual description |
|
Mechanism of action |
|
Routes of administration |
|
Effects sought out by the user
The effects are similar to those of alcohol, barbiturates and benzodiazepines. However, they come on much more quickly and are brief. Their effects vary depending on the individual, the product and amount inhaled and how it is inhaled:
- Euphoria (with regards to nitrous oxide, euphoria is often accompanied by laughing, hence the nickname "laughing gas")
- Loss of inhibition
- Transient stimulation followed by drowsiness that occasionally results in a semi-conscious state.
Common toxic effects and caused by high doses
- Aggressive behaviour
- Confusion
- Disorientation
- Dizziness
- Drowsiness
- Generalized muscle weakness
- Headache
- Irrational behaviour
- Nausea
- Significantly impaired judgement
- Slurred speech
- Uncoordinated movements
- Vomiting
Toxic effects resulting from overdose
- Cardiac arrest
- Coma
- Convulsions
- Death
- Decreased heartbeats
- Irregular heart rate
- Respiratory depression
Effects associated with chronic use
- Amnesia
- Ataxia (uncoordinated movements)
- Bone marrow depression (blood disorders)
- Impotence
- Paranoid delusions
- Peripheral polyneuropathy (numbness, paralysis) that is reversible when the user quits
- Visual hallucinations
- Kidney damage
- Liver damage
- Weakened immune system
Tolerance (need to increase the dose to feel the same effect)
Not documented.
Addiction
Psychological dependence affects only 3.7% of those who experiment with these substances.
Withdrawal
Does not appear to be associated with any withdrawal syndrome. However, certain symptoms may occur when a substance is discontinued:
- Excessive sweating
- Feeling of weightlessness
- Irritability
- Nausea
- Sleep disorders
- Tremors
Route of administration | Onset of action | Peak | Duration of action |
---|---|---|---|
Intrapulmonary (inhaled) | Almost immediate | N/A | About 15 minutes after stopping inhalation. Residual effects may persist for 1 to 2 hours. |
Intoxication management
- No antidote available.
- Treatment is mainly symptomatic.
If you need help or want to learn more:
[UNIPRIX] © Copyright Vigilance Santé
The patient information leaflets are provided by Vigilance Santé Inc. This content is for information purposes only and does not in any manner whatsoever replace the opinion or advice of your health care professional. Always consult a health care professional before making a decision about your medication or treatment.